Health Care & Life Sciences » Pharmaceuticals | Northeast Tiger Pharmaceutical Co. Ltd.

Northeast Tiger Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,398.20
6.30
576.50
68,837.30
1,103.20
7,313.10
Total Accounts Receivable
7.70
9,766.10
6,153.70
55,402.80
11,763.20
2,605.70
Inventories
26,495.60
29,159.40
29,811.40
32,281.10
-
-
Other Current Assets
1,369.20
-
-
-
40,411.80
31,498.90
Total Current Assets
32,270.70
38,931.70
36,541.60
156,521.10
53,278.20
41,417.80
Net Property, Plant & Equipment
41,548.70
41,259.20
42,001.90
43,500.00
44,679.40
616.90
Total Investments and Advances
-
-
-
-
83,669.80
79,596.90
Long-Term Note Receivable
-
28,204.50
26,634.30
24,316.50
-
-
Intangible Assets
-
16,092.20
14,479.60
7,815.10
7,930.10
5,306.10
Other Assets
113,809.40
11,706.00
10,882.40
9,898.00
-
-
Total Assets
187,628.70
136,193.60
130,539.70
242,050.70
189,557.50
126,937.70
ST Debt & Current Portion LT Debt
12,807.90
12,499.80
-
-
-
Accounts Payable
4,467.40
4,359.90
4,162.90
1,671.20
6,249.50
Income Tax Payable
1,376.80
998.70
952.40
1,667.90
-
Other Current Liabilities
2,381.00
2,318.70
1,705.50
3,634.80
6,424.80
Total Current Liabilities
21,033.10
20,177.10
6,820.90
6,973.90
12,674.30
Long-Term Debt
40,472.80
28,124.50
26,853.90
25,101.90
27,010.00
Deferred Taxes
-
-
-
-
17,446.10
Other Liabilities
1,857.10
-
-
-
-
Total Liabilities
63,363.00
48,301.60
33,674.80
32,075.80
57,130.40
Common Equity (Total)
124,265.70
87,892.10
96,864.90
201,190.30
140,770.20
Total Shareholders' Equity
124,265.70
87,892.10
96,864.90
201,190.30
140,770.20
Total Equity
124,265.70
87,892.10
96,864.90
209,974.90
132,427.10
Liabilities & Shareholders' Equity
187,628.70
136,193.60
130,539.70
242,050.70
189,557.50
Accumulated Minority Interest
-
-
-
8,784.60
8,343.10

About Northeast Tiger Pharmaceutical Co.

View Profile
Address
255-257 Des Voeux Road Central
Hong Kong
Hong Kong
Employees -
Website http://www.northeasttiger.com
Updated 07/08/2019
Baytacare Pharmaceutical Co. Ltd. engages in the development, manufacture, and sale of medicines. It operates through the following segments: Medicine Business, Chinese Herbs Business, Trading Business, and Big Data Business. The Medicine Business segment develops, manufactures, and sells medicines.